Improved survival with screening for hepatocellular carcinoma

Liver Transplantation

Volumn 6, Issue 3, 2000, Pages 320-325

  Wong, Linda L ^a,b   Limm, Whitney M ^a   Severino, Richard ^a   Wong, Livingston M ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; DEMOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

EID: 0034027972     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/lv.2000.4875     Document Type: Article

References (16)

1. Simonetti RG, Camma C, Fiorello F. Hepatocellular carcinoma: A worldwide problem and the major risk factors. Dig Dis Sci 1991;35:962-972.
2. Carriage MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75(suppl):171-190.
3. Di Bisceglie A, Hoofnagle JH. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 1989;64:2117-2120.
4. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-687.
5. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-680.
6. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432-438.
7. Cottone M, Virdone R, Fusco G, Orlando A, Turri M, Caltagirone M, et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis: A comparison of natural history and surgical treatment. Gastroenterology 1989;96:1566-1571.
8. Di Bisceglie AM. Hepatocellular carcinoma (NIH conference). Ann Intern Med 1988;108:390-401.
9. Landis SH, Murray T, Bolden S. Cancer Statistics 1998. CA Cancer J Clin 1998;48:6-29.
10. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1984;19:61-66.
11. Liaw YF, Tai DI, Chu CM, Lin DY, Sheen IS, Chen TJ, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. Gastroenterology 1986;90:263-367.
12. Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography: A study in 51 patients. Gastroenterology 1984;86:495-502.
13. Lok AS, Lai CL. Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: Role in early detection of hepatocellular carcinoma. Hepatology 1989;9:110-115.
14. Chen DS, Sung JL, Sheu JC, Lai MY, How SW, Hsu HC, et al. Serum alpha-fetoprotein. I: The early stage of human hepatocellular carcinoma. Gastroenterology 1984;86:1404-1409.
15. Curley SA, Izzo F, Gallipoli A, de Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 1995;222:375-383.
16. Heyward WL, Lanier AP, McMahon BJ, Fitzgerald MA, Kilkenny S, Paprocki TR. Early detection of primary hepatocellular carcinoma. JAMA 1985;254:3052-3054.